¼¼°èÀÇ ¹ÙÀÌ¾Ë ¾î´ðÅÍ ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)
Vial Adaptors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
»óǰÄÚµå : 1822615
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 140 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 6,975,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,701,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,009,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Global Market Insights, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ ¹ÙÀÌ¾Ë ¾î´ðÅÍ ½ÃÀåÀº 2024³â¿¡ 10¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2025³â 11¾ï ´Þ·¯¿¡¼­ 2034³â±îÁö 19¾ï ´Þ·¯·Î ¼ºÀåÇØ CAGR 6.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ºÐ¾ßÀÇ ±â¼¼´Â ¾ÈÀüÇÑ ¾à¹°ÀÇ ¹«±Õ À籸¼º°ú ¿¹¹æ Á¢Á¾, º´¿ø ¹× ÀÓ»ó ȯ°æ¿¡¼­ ¿À¿° À§ÇèÀ» ÁÙÀÌ´Â ½ÃÀå ¿ä±¸¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¾Ë ¾î´ðÅÍ Market-IMG1

¹ÙÀÌ¾Ë ¾î´ðÅʹ ƯÈ÷ Áß¿äÇÑ Ä¡·á, Á¾¾çÇÐ, ¹é½Å Åõ¿©¿Í °°Àº Áß¿äÇÑ È¯°æ¿¡¼­ ÁÖ»çÁ¦ÀÇ ÀÌ¼Û ¹× À籸¼º ½Ã "¹Ù´ÃÀÌ ¾ø´Â" Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ¾ÈÀü¼º°ú È¿À²¼º Çâ»ó¿¡ ±â¿©ÇÕ´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀå ¸ÅÃâ 10¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 19¾ï ´Þ·¯
CAGR 6.5%

ÁÖ¿ä ÃËÁø¿äÀÎ

1. »ý¹°Á¦Á¦ ¹× ¹é½Å »ç¿ë Áõ°¡ : »ý¹°ÇÐÀû Á¦Á¦ Áõ°¡ ¹× ¹é½ÅÁ¢Á¾ ÇÁ·Î±×·¥ È®´ë·Î ¾ÈÀüÇϰí È¿À²ÀûÀÎ À籸¼º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

2. °¨¿° ¿¹¹æ ¹× ¾ÈÀü ¹®Á¦ : ¹ÙÀÌ¾Ë ¾î´ðÅÍ´Â ¹Ù´Ã Â±â »ç°í¿Í ¹Ì»ý¹° ¿À¿°À» ¹æÁöÇÏ°í ¹Ù´ÃÀÌ ¾ø´Â Æó¼â ½Ã½ºÅÛÀ¸·Î ¾à¹° Àü´ÞÀ» Á¦°øÇÕ´Ï´Ù.

3. º´¿ø ¹× ÀÓ»ó ¿öÅ©Ç÷οìÀÇ °£¼ÒÈ­ : ¹ÙÀÌ¾Ë ¾î´ðÅÍ Á¦Ç°Àº ¾à¹° Áغñ¸¦ ¿ëÀÌÇÏ°Ô ÇÏ°í ½Ã°£À» Àý¾àÇÏ°í ¾à¹° ½Ç¼ö¸¦ ÃÖ¼ÒÈ­ÇÕ´Ï´Ù.

4. Æó¼âÇü ½Ã½ºÅÛ ¾à¹°Àü´Þ ÀåÄ¡(CSTD)¿¡ ´ëÇÑ ±ÔÁ¦ µÞ¹Þħ : Ç×¾ÏÁ¦³ª À§ÇèÇÑ ¾à¹°À» Ãë±ÞÇϱâ À§ÇØ CSTD¸¦ »ç¿ëÇÏ´Â °ÍÀÌ ¼¼°èÀûÀ¸·Î ±ÇÀåµÇ¸ç, ¹ÙÀÌ¾Ë ¾î´ðÅÍÀÇ Ã¤¿ëÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷

West Pharmaceutical Services, Thermo Fisher Scientific, Becton, Dickinson and Company, ICU Medical µî ÁÖ¿ä ±â¾÷ÀÌ 44.4%ÀÇ ´©Àû ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

West´Â ±¹³» ¹ÙÀÌ¾Ë ¾î´ðÅÍ °ø±Þ¾÷üÀÇ ÅéÀ¸·Î, 2024³â ½ÃÀå Á¡À¯À²Àº 21.2%¿´½À´Ï´Ù.

ÁÖ¿ä °úÁ¦

1. Á¦Ç° À¯Çüº° - ÀÏȸ¿ë ¹ÙÀÌ¾Ë ¾î´ðÅÍ ¸®µå

ÀÏȸ¿ë ¹ÙÀÌ¾Ë ¾î´ðÅÍ´Â 2024³â ½ÃÀå ¸®´õ·Î º¸´Ù ¿ì¼öÇÑ °¨¿° °ü¸®, ±ÔÁ¦ Áؼö, º´¿ø ¹× ¿¬±¸¼ÒÀÇ ÀÓ»ó ÇöÀå¿¡¼­ÀÇ »ç¿ë ÆíÀǼºÀ» ¹ÙÅÁÀ¸·Î Çß½À´Ï´Ù. È­Çпä¹ý, ¿¹¹æÁ¢Á¾, ÁßÁõ ȯÀÚ¿ë ¾àÁ¦Á¶Á¦¿¡ ¿ì¼±ÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

2. »çÀÌÁî-20mm À¯´Ï¹ö¼³ ¿ëµµ¿ë

20mm Å©±â´Â Á¾¾çÇÐ, °¨¿°, ¼Ò¾Æ°ú °ü·Ã Ä¡·á ¿µ¿ª¿¡ º¸ÆíÀûÀÎ Àû¿ë °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù.

3.¼ÒÀ纰 - Æú¸®Ä«º¸³×ÀÌÆ®°¡ 1À§¿¡ °øÇå

2024³â¿¡´Â ³»±¸¼º, ³»¾àǰ¼º, ¹ÙÀÌ¾Ë ¾î´ðÅÍ¿¡¼­ ÁÖ»ç±â·Î ¾à¹° ÁÖÀÔ ½Ã À°¾È °Ë»ç¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â Åõ¸í¼ºÀ» ¹ÙÅÁÀ¸·Î Æú¸®Ä«º¸³×ÀÌÆ® ±â¹Ý ¹ÙÀÌ¾Ë ¾î´ðÅͰ¡ ¼±µµÇϰí ÀÖ½À´Ï´Ù.

4. ÃÖÁ¾ ¿ëµµº° - º´¿øÀÌ ¼ö¿äÀÇ Áß½É

º´¿øÀº 2024³â¿¡µµ ¹ÙÀÌ¾Ë ¾î´ðÅÍÀÇ ÁÖ¿ä ÃÖÁ¾ ¿ëµµÀÔ´Ï´Ù. ¿Ö³ÄÇϸé, º´¿ø¿¡¼­´Â ƯÈ÷ Á¾¾ç°ú³ª °¨¿°Áõ°ú µîÀÇ °íȯÀÚ¼ö¿¡ ´ëÀÀÇϱâ À§ÇØ, ¹«±ÕÀÌ°í ºñ¿ë È¿À²ÀûÀÎ ¾àÁ¦ Åõ¿© ½Ã½ºÅÛÀÌ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù.

5. Áö¿ªº°-ºÏ¹Ì°¡ °è¼Ó ¿ì¼¼

ºÏ¹Ì´Â ÇコÄɾî ÀÎÇÁ¶ó¿Í °í±Þ ¾à¹°Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¿Õ¼ºÇÑ ÅõÀÚ·Î ¹ÙÀÌ¾Ë ¾î´ðÅÍ ¼¼°è ½ÃÀåÀ» °è¼Ó Áö¹èÇϰí ÀÖ½À´Ï´Ù. Æó¼âÇü ¾à¹° Àü´Þ ÀåÄ¡(CSTD)ÀÇ »ç¿ë°ú °¨¿° ¿¹¹æÀÇ ÃßÁøÀº ÀÌ Áö¿ªÀÇ ¼ºÀåÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¸¸¼º Áúȯ Áõ°¡, °Ç°­ °ü¸®¿¡ ´ëÇÑ °í¾× ÁöÃâ, °ÇÀüÇÑ º´¿ø ÀÎÇÁ¶ó¿¡ ÈûÀÔ¾î 2024³â ¹ÙÀÌ¾Ë ¾î´ðÅÍ ¼¼°è ½ÃÀåÀ» ¼®±ÇÇß½À´Ï´Ù. ÀÌ Áö¿ª¿¡´Â À¯¸íÇÑ Á¦¾à ȸ»ç¿Í »ý¸í °øÇРȸ»çµµ ¸¹¾Æ ¹«±Õ Á¦Á¦¿¡ ¹ÙÀÌ¾Ë ¾î´ðÅÍÀÇ Ã¤¿ëÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ¹é½Å Á¢Á¾ Áõ°¡, ÇÁ¸®Çʵå ÁÖ»ç±â ¹× ¹ÐÆóÇü ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ »ç¿ë È®´ë·Î °è¼ÓÇØ¼­ Å« °øÇåÀ» Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ¹ÙÀÌ¾Ë ¾î´ðÅÍ ½ÃÀå ±â¾÷À¸·Î´Â B. Braun, Baxter International, Becton, Dickinson and Company, West Pharmaceutical Services, Yukon Medical, Thermo Fisher Scientific, ICU Medical, Helapet, Epic Medical, CODAN Medizinische Gerate, Miltenyi Biotec, EQUASHIELD, VYGON µîÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ½ÃÀå ¸®´õ´Â Á¦Ç° Çõ½Å, Á¦ÈÞ ¹× ±ÔÁ¦ ´ç±¹ÀÇ Çã°¡¿¡ º£ÆÃÇϰí ÀÖ½À´Ï´Ù. Becton, Dickinson and Company ¹× Baxter InternationalÀº ¿À¿°À» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¹ÙÀÌ¾Ë ¾î´ðÅ͸¦ ÁÖÀÔ ¹× »çÀü ÃæÀü ÁÖ»ç±â Ç÷§Æû¿¡ ÅëÇÕÇÕ´Ï´Ù. ¶ÇÇÑ °¢ ȸ»ç´Â ´Ù¾çÇÑ º´¿øÀÇ ÇÊ¿ä¿Í ¾àÁ¦ÀÇ Çü½ÄÀ» ÃæÁ·Çϱâ À§ÇØ Áö¼Ó °¡´ÉÇÑ Àç·á¿Í ¸ÂÃãÇü Å©±âÀÇ ¾î´ðÅÍ¿¡ ÀÚ±ÝÀ» ÁöÃâÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°, 2021-2034³â

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç° »çÀÌÁ, 2021-2034³â

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Àç·áº°, 2021-2034³â

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2034³â

Á¦9Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°, 2021-2034³â

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global vial adaptors market was valued at USD 1 billion in 2024 and is projected to grow from USD 1.1 billion in 2025 to USD 1.9 billion by 2034, registering a CAGR of 6.5%, according to the latest report by Global Market Insights, Inc. The sector's momentum has been driven by market needs for safe drug sterile reconstitution and vaccinations, as well as a need to mitigate contamination risk in hospitals and clinical environments.

Vial Adaptors Market - IMG1

Vial adaptors help improve safety and efficiency by enabling 'needle-free' access when transferring and reconstituting injectable drugs, particularly in critical settings such as critical care, oncology, and vaccine administration.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1 Billion
Forecast Value$1.9 Billion
CAGR6.5%

Key Drivers:

1. Increasing use of biologics and vaccines: Increasing numbers of biologic drugs and expanding vaccination programs have increased demand for safe and efficient reconstitution.

2. Infection prevention and safety issues: Vial adaptors provide needle-free, closed-system medication delivery, preventing needlestick accidents and microbial contamination.

3. Streamlining hospital and clinical workflow: These products make drug preparation easier, saving time and minimizing drug errors.

4. Regulatory push to close-system transfer devices (CSTDs): Global recommendations for using CSTDs for cancer and hazardous drug handling are accelerating vial adaptor adoption.

Key Players:

Major players like West Pharmaceutical Services, Thermo Fisher Scientific, Becton, Dickinson and Company, and ICU Medical hold a cumulative market share of 44.4%.

West is the leading domestic vial adaptor supplier with 21.2% market share in 2024.

Key Challenges:

1. By Product Type - Single-Use Vial Adaptors Lead

Single-use vial adaptors were the market leader in 2024 due to their better infection control, regulatory compliance, and ease of use in hospitals and laboratory clinical settings. They are used in preference in chemotherapy, immunization, and critical care drug preparation.

2. Size - 20mm For Universal Application

A 20mm size offers universal applicability to therapy areas related to oncology, infectious diseases, and pediatrics.

3. Based on Material - Polycarbonate Contributes to 1ST Position

In 2024, polycarbonate based vial adaptors lead the way, based upon durability, chemical resistance, and transparency permitting visual inspection during the transfer of the drug from the vial adapter to the syringe.

4. By End Use - Hospitals Power Core Demand

Hospitals continued to be the major End Uses of vial adaptors in 2024, since such facilities need aseptic, cost-effective drug administration systems to meet high patient loads, particularly in oncology and infectious disease departments.

5. By Region - North America Continues to Dominate

North America continued to dominate the global market for vial adaptors with strong investments in healthcare infrastructure and advanced drug delivery systems. The usage of closed-system transfer devices (CSTDs) and promotion of infection prevention practices additionally enhance regional growth. North America dominated the world vial adaptors market in 2024, aided by increasing numbers of chronic diseases, high expenditure on healthcare, and sound hospital infrastructure. The region is also home to a number of prominent pharmaceutical and biotechnology companies, further driving the adoption of vial adaptors in sterile drug preparation. The US continues to be a dominant contributor because of growing vaccination efforts and extensive use of prefilled syringes and closed drug delivery systems.

Some of the major vial adaptors market players are B. Braun, Baxter International, Becton, Dickinson and Company, West Pharmaceutical Services, Yukon Medical, Thermo Fisher Scientific, ICU Medical, Helapet, Epic Medical, CODAN Medizinische Gerate, Miltenyi Biotec, EQUASHIELD, and VYGON.

Market leaders are placing bets on product innovation, collaborations, and regulatory clearances to remain competitive. An example of this is West Pharmaceutical Services, which continues to expand its portfolio of vial adaptors to facilitate safe reconstitution of biologics.;Becton, Dickinson and Company and Baxter International are incorporating vial adaptors into their infusion and prefilled syringe platforms to minimize contamination. Also, companies are spending money on sustainable materials/ adaptors of custom sizes to satisfy different hospital needs and drug formats.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2024

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Product Size, 2021 - 2034 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â